B. Jackson

发表

Enalapril (MK421) activation in man: importance of liver status.

C. Johnston, I. Larmour, B. Jackson, 1985, British journal of clinical pharmacology.

The contribution of systemic hypertension to progression of chronic renal failure in the rat remnant kidney: effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor.

C. Johnston, B. Jackson, 1988, Journal of hypertension.

Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat.

C. Johnston, B. Jackson, L. Franze, 1990, The Journal of laboratory and clinical medicine.

Effect of angiotensin-converting enzyme inhibitor dosing interval on functional parameters in patients with chronic heart failure.

H. Krum, L. Howes, P. Leslie, 1998, American heart journal.

INCREASED CARDIAC ANGIOTENSIN‐CONVERTING ENZYME IN RATS WITH CHRONIC HEART FAILURE

C. Johnston, M. Kohzuki, B. Fabris, 1990, Clinical and experimental pharmacology & physiology.

Localization of angiotensin converting enzyme in rat heart.

C. Johnston, A. Allen, B. Fabris, 1991, Circulation research.

ANGIOTENSIN CONVERTING ENZYME IN THE RAT HEART: STUDIES OF ITS INHIBITION IN VITRO AND EX VIVO

C. Johnston, B. Fabris, B. Jackson, 1989, Clinical and experimental pharmacology & physiology.

Angiotensin converting enzyme inhibition in plasma and tissues.

C. Johnston, K. Sakaguchi, B. Jackson, 1987, Clinical and experimental hypertension. Part A, Theory and practice.

Inhibition of tissue angiotensin converting enzyme. Quantitation by autoradiography.

C. Johnston, F. Mendelsohn, K. Sakaguchi, 1988, Hypertension.

Characterization of angiotensin converting enzyme (ACE) in the testis and assessment of the in vivo effects of the ACE inhibitor perindopril.

C. Johnston, K. Sakaguchi, B. Jackson, 1988, Endocrinology.

Effects of Perindopril on Tissue Angiotensin‐Converting Enzyme Activity Demonstrated by Quantitative in vitro Autoradiography

C. Johnston, F. Mendelsohn, S. Chai, 1988, Journal of cardiovascular pharmacology.

Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.

C. Johnston, B. Jackson, R. Cubela, 1984, Journal of hypertension.

Inhibition of tissue angiotensin converting enzyme by perindopril: in vivo assessment in the rat using radioinhibitor binding displacement.

C. Johnston, B. Jackson, R. Cubela, 1988, The Journal of pharmacology and experimental therapeutics.

Differential angiotensin-converting enzyme inhibition in brain after oral administration of perindopril demonstrated by quantitative in vitro autoradiography.

C. Johnston, F. Mendelsohn, K. Sakaguchi, 1988, Neuroendocrinology.

Inhibition of angiotensin converting enzyme (ACE) in plasma and tissues: studies ex vivo after administration of ACE inhibitors.

C. Johnston, M. Kohzuki, B. Fabris, 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

RELATIVE INHIBITORY POTENCY AND PLASMA DRUG LEVELS OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN THE RAT

C. Johnston, B. Jackson, R. Cubela, 1988, Clinical and experimental pharmacology & physiology.

Angiotensin-converting enzyme (ACE) measurement in human serum using radioinhibitor ligand binding.

C. Johnston, B. Jackson, R. Cubela, 1986, The Australian journal of experimental biology and medical science.

GENOTYPIC INFLUENCE ON PLASMA DIPEPTIDYL CARBOXYPEPTIDASE‐1 ACTIVITY IN HYPERTENSIVES

B. Morris, G. Stokes, B. Jackson, 1994, Clinical and experimental pharmacology & physiology.

Systemic and renovascular hypertension.

B. Jackson, L. Franze, M. Whitty, 1992, The Tohoku journal of experimental medicine.

Controlled trial of enalapril in congestive cardiac failure.

C. Johnston, G. Jennings, H. Kiat, 1985, British heart journal.

PRESERVATION OF RENAL FUNCTION IN THE RAT REMNANT KIDNEY MODEL OF CHRONIC RENAL FAILURE BY BLOOD PRESSURE REDUCTION

C. Johnston, B. Jackson, R. Cubela, 1986, Clinical and experimental pharmacology & physiology.

Controlled trial of enalapril in congestive cardiac failure.

C. Johnston, G. Jennings, H. Kiat, 1985, British heart journal.

BLOCKADE OF ANGIOTENSIN CONVERTING ENZYME IN CIRCUMVENTRICULAR ORGANS OF THE BRAIN AFTER ORAL LISINOPRIL ADMINISTRATION DEMONSTRATED BY QUANTITATIVE IN VITRO AUTORADIOGRAPHY

C. Johnston, F. Mendelsohn, S. Chai, 1987, Clinical and experimental pharmacology & physiology.

Pharmacokinetics of angiotensin converting enzyme inhibitors in plasma and tissue using radioinhibitor binding and displacement assays.

C. Johnston, B. Jackson, R. Cubela, 1989, Advances in experimental medicine and biology.

Characterization of cardiac angiotensin converting enzyme (ACE) and in vivo inhibition following oral quinapril to rats

C. Johnston, F. Mendelsohn, B. Jackson, 1990, British journal of pharmacology.

Distribution and Functional Significance of Cardiac Angiotensin Converting Enzyme in Hypertrophied Rat Hearts

H. Schunkert, B. Lorell, F. Schoen, 1993, Circulation.

Tissue Angiotensin Converting Enzyme (ACE) During Changes in the Renin—Angiotensin System

C. Johnston, B. Jackson, R. Cubela, 1987, Journal of cardiovascular pharmacology.

MESENTERIC RESISTANCE AND BRAIN MICROVASCULAR ANGIOTENSIN‐CONVERTING ENZYME IN THE SPONTANEOUSLY HYPERTENSIVE RAT

C. Johnston, B. Jackson, K. Jandeleit, 1992, Clinical and experimental pharmacology & physiology.

Angiotensin converting enzyme (ACE), characterization by 125I-MK351A binding studies of plasma and tissue ACE during variation of salt status in the rat.

C. Johnston, B. Jackson, R. Cubela, 1986, Journal of hypertension.

Differential renal function during angiotensin converting enzyme inhibition in renovascular hypertension.

C. Johnston, B. McGrath, P. G. Matthews, 1986, Hypertension.

EFFECT OF GLYCAEMIC CONTROL ON GLOMERULAR FILTRATION RATE IN THE STREPTOZOTOCIN DIABETIC RAT

G. Jerums, M. Cooper, R. O’Brien, 1988, Clinical and experimental pharmacology & physiology.

ATRIAL NATRIURETIC FACTOR IN CHRONIC RENAL FAILURE: STUDIES IN MAN AND THE RAT

C. Johnston, G. P. Hodsman, B. Jackson, 1987, Clinical and experimental pharmacology & physiology.

Plasma Atrial Natriuretic Factor in Pregnancy

C. Johnston, G. P. Hodsman, B. Jackson, 1987 .

Chronic angiotensin converting enzyme inhibition in the two‐kidney, one clip hypertensive rat

C. Johnston, B. Jackson, L. Franze, 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

ANGIOTENSIN CONVERTING ENZYME INHIBITION IN RENOVASCULAR HYPERTENSION: FREQUENCY OF REVERSIBLE RENAL FAILURE

C. Johnston, B. McGrath, P. G. Matthews, 1984, The Lancet.

Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension.

C. Johnston, I. Larmour, B. Jackson, 1984, British journal of clinical pharmacology.

Mechanism for hypotensive action of angiotensin converting enzyme inhibitors.

C. Johnston, L. Arnolda, B. Jackson, 1984, Clinical and experimental hypertension. Part A, Theory and practice.

Pharmacology of Agents Acting on the Renin-Angiotensin System

C. Johnston, B. Jackson, 1983, Anaesthesia and intensive care.

Characterisation of angiotensin converting enzyme from different rat vascular beds.

C. Johnston, K. Jandeleit-Dahm, B. Jackson, 1995, Blood pressure.

ANGIOTENSIN‐CONVERTING ENZYME IN MACRO‐AND MICROVESSELS OF THE RAT

C. Johnston, B. Jackson, K. Jandeleit, 1991, Clinical and experimental pharmacology & physiology.

CHARACTERIZATION OF ANGIOTENSIN CONVERTING ENZYME FROM RAT TISSUE BY RADIO‐INHIBITOR BINDING STUDIES

C. Johnston, B. Jackson, R. Cubela, 1986, Clinical and experimental pharmacology & physiology.

Relationship of antihypertensive effect of enalapril to serum MK-422 levels and angiotensin converting enzyme inhibition.

C. Johnston, L. Arnolda, B. McGrath, 1983, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

CARDIAC HYPERTROPHY IN DIABETIC SPONTANEOUSLY HYPERTENSIVE RATS: ROLE OF ANGIOTENSIN II?

C. Johnston, T. Briscoe, J. Bertram, 1997, Clinical and experimental pharmacology & physiology.

Clinical and Haemodynamic Effects of Minoxidil in Refractory Hypertension

J. Lawrence, A. Clarkson, B. Jackson, 2012, Drugs.

Felodipine in combination with a beta-adrenoceptor blocker as an effective substitute for triple therapy in severe hypertension. The Australian Felodipine Multicentre Study Group.

R. Wyndham, B. Jackson, D. Frewin, 1991, European journal of clinical pharmacology.

PHARMACOKINETICS OF ANGIOTENSIN CONVERTING ENZYME INHIBITION IN TISSUES FOLLOWING ORAL LISINOPRIL: STUDIES IN THE RAT USING QUANTITATIVE RADIOINHIBITOR BINDING

C. Johnston, K. Sakaguchi, B. Jackson, 1987, Clinical and experimental pharmacology & physiology.

MESENTERIC VASCULAR ANGIOTENSIN‐CONVERTING ENZYME IS INCREASED IN EXPERIMENTAL DIABETES MELLITUS

M. Cooper, J. Rumble, B. Jackson, 1992, Clinical and experimental pharmacology & physiology.

Measurement of angiotensin converting enzyme induction and inhibition using quantitative in vitro autoradiography: tissue selective induction after chronic lisinopril treatment.

C. Johnston, M. Kohzuki, B. Jackson, 1991, Journal of hypertension.

Glomerular Filtration Rate in Streptozocin-Induced Diabetic Rats: Role of Exchangeable Sodium, Vasoactive Hormones, and Insulin Therapy

G. Jerums, R. O’Brien, T. Allen, 1990, Diabetes.

Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II.

H. Schunkert, H. Jacob, J. Ingelfinger, 1992, The American journal of physiology.

ACUTE AND CHRONIC EFFECTS OF ANGIOTENSIN‐CONVERTING ENZYME INHIBITORS ON TISSUE ANGIOTENSIN‐CONVERTING ENZYME

C. Johnston, S. Chai, B. Jackson, 1992, Clinical and experimental pharmacology & physiology. Supplement.

THE TISSUE RENIN‐ANGIOTENSIN SYSTEM AND ITS FUNCTIONAL ROLE

C. Johnston, L. Burrell, B. Jackson, 1992, Clinical and experimental pharmacology & physiology. Supplement.

Measurement of angiotensin converting enzyme inhibitors in serum by radioinhibitor binding displacement assay.

C. Johnston, B. Jackson, R. Cubela, 1987, Biochemical Pharmacology.

ANGIOTENSIN CONVERTING ENZYME DURING ACUTE AND CHRONIC ENALAPRIL THERAPY IN ESSENTIAL HYPERTENSION

B. Jackson, C. I. Johnstoa, 1984, Clinical and experimental pharmacology & physiology.

Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors.

C. Johnston, B. Fabris, B. Jackson, 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Lack of cross sensitivity between captopril and enalapril.

C. Johnston, B. McGrath, P. G. Matthews, 1988, Australian and New Zealand journal of medicine.

EFFECT OF ENALAPRIL TREATMENT ON PROGRESSION OF THE NEPHROTOXIC SERUM NEPHRITIS MODEL OF RENAL FAILURE IN THE RAT

B. Jackson, L. Debrevi, 1988, Clinical and experimental pharmacology & physiology.

PLASMA ATRIAL NATRIURETIC PEPTIDE: CONCENTRATIONS AND CIRCULATING FORMS IN NORMAL MAN AND PATIENTS WITH CHRONIC RENAL FAILURE

C. Johnston, E. Woodcock, G. P. Hodsman, 1987, Clinical and experimental pharmacology & physiology.

COMPARISON OF THE PHARMACOKINETICS AND PHARMACODYNAMICS OF PERINDOPRIL, CILAZAPRIL AND ENALAPRIL

H. Krum, B. Workman, E. Conway, 1992, Clinical and experimental pharmacology & physiology. Supplement.

Angiotensin‐Converting Enzyme Inhibitors: Measurement of Relative Inhibitory Potency and Serum Drug Levels by Radioinhibitor Binding Displacement Assay

C. Johnston, B. Jackson, R. Cubela, 1987, Journal of cardiovascular pharmacology.

Steady‐State Pharmacokinetics and Pharmacodynamics of Cilazapril in the Presence and Absence of Cyclopenthiazide

C. Johnston, H. Krum, L. Howes, 1992, Journal of cardiovascular pharmacology.

Felodipine versus Prazosin as an Addition to a β-Blocker in the Treatment of Essential Hypertension

Trefor Owen Morgan, B. Jackson, A. Anderson, 2012, Drugs.

Felodipine in combination with a β-adrenoceptor blocker as an effective substitute for triple therapy in severe hypertension

R. Wyndham, B. Jackson, D. Frewin, 2004, European Journal of Clinical Pharmacology.

Structural constraints of inhibitors for binding at two active sites on somatic angiotensin converting enzyme.

C. Johnston, B. Jackson, R. Perich, 1994, European journal of pharmacology.

Renovascular hypertension

C. Johnston, B. McGrath, P. G. Matthews, 1983, Medical Journal of Australia.

Angiotensin‐Converting Enzyme Inhibition: Prospects for the Future

C. Johnston, B. Jackson, Mendelsohn, 1991, Journal of cardiovascular pharmacology.

Correlation between angiotensin converting enzyme inhibition and the acute hypotensive response to MK 421 in essential hypertension.

C. Johnston, B. McGrath, B. Jackson, 1982, Clinical and experimental pharmacology & physiology. Supplement.

Changes in the renin-angiotensin system, exchangeable body sodium, and plasma and atrial content of atrial natriuretic factor during evolution of chronic renal failure in the rat.

C. Johnston, P. Hodsman, B. Jackson, 1988, American journal of hypertension.

Angiotensin-converting enzyme inhibition in renal disease; contrasting effects on renal function in renal artery stenosis and progressive renal injury.

C. Johnston, B. Jackson, 1989, Journal of human hypertension.

Acute and chronic effects of perindopril on tissue angiotensin converting enzyme activity.

C. Johnston, B. Jackson, R. Cubela, 1991, American journal of hypertension.

Treatment of hypertension with angiotensin converting enzyme inhibitors.

C. Johnston, B. McGrath, P. G. Matthews, 1982, Clinical and experimental pharmacology & physiology. Supplement.

Salt Blocks the Renal Benefits of Ramipril in Diabetic Hypertensive Rats

C. Johnston, B. Fabris, B. Jackson, 1991, Hypertension.

HIGH SALT DIET AMELIORATES EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITION IN SPONTANEOUSLY HYPERTENSIVE STREPTOZOTOCIN DIABETIC RATS

C. Johnston, B. Fabris, B. Jackson, 1990, Clinical and experimental pharmacology & physiology.

Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies.

C. Johnston, B. Jackson, F. Mendelsohn, 1992, Molecular pharmacology.

Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat.

C. Johnston, B. Jackson, R. Cubela, 1987, Journal of cardiovascular pharmacology.

Preservation of Renal Structure and Function in the Rat Remnant Kidney Model of Chronic Renal Failure by Enalapril Treatment

B. Jackson, R. Cubela, L. Debrevi, 1987, Pathology.

Lisinopril pharmacokinetics in chronic renal failure.

C. Johnston, E. Conway, B. Jackson, 1988, British journal of clinical pharmacology.

ANGIOTENSIN CONVERTING ENZYME AND SUBSTANCE P CHANGES IN BLISTER FLUID FOLLOWING AFFERENT NERVE STIMULATION IN THE RAT

R. Helme, B. Jackson, R. Cubela, 1985, Clinical and Experimental Pharmacology and Physiology.

Evaluation of Angiotensin Converting Enzyme (ACE) in the Pharmacokinetics and Pharmacodynamics of ACE Inhibitors

C. Johnston, L. Arnolda, I. Larmour, 1986, Journal of Cardiovascular Pharmacology.

Lisinopril pharmacokinetics inchronic renal failure

C. Johnston, E. Conway, B. Jackson, 1988 .